Prolong Pharmaceuticals Moves Into New Headquarters / by TI

Prolong Pharmaceuticals LLC announced the expansion of its South Plainfield, N.J., manufacturing facility. A new long-term lease on the space adjoining its current facility is adding 24,000 square feet to the existing 24,000 square feet. In addition, the company secured 12,000 square feet of new executive and administrative space in South Plainfield, which will serve as its new headquarters.

The South Plainfield manufacturing facility has been used by Prolong since early 2010 and has been producing large scale biological product in a cGMP environment of Prolong's oxygen transfer agent, SANGUINATE™. “As our clinical plans have advanced, we are executing our facilities plan as well,” said Prolong's president Glenn Kazo. “We secured our initial plant with a long term lease in 2011, and we brought in an industry veteran as head of manufacturing and facilities, Tom Flachmeyer. This expansion and the establishment of our new separate corporate offices is on pace with our strategic schedule.”